revers
transcriptasepolymeras
chain
reaction
rtpcr
assay
detect
felin
coronaviru
fcov
genom
cocultiv
method
isol
field
strain
fcov
describ
use
rtpcr
assay
assess
blood
sampl
cat
felin
infecti
periton
fip
healthi
cat
household
endem
fcov
shown
approxim
cat
viraem
irrespect
health
statu
also
shown
period
similar
percentag
healthi
cat
remain
viraem
presenc
viraemia
appear
predispos
cat
develop
fip
cocultiv
system
prove
suitabl
method
cultur
field
strain
fcov
blood
sampl
long
cultur
maintain
least
week
use
system
follow
rtpcr
viraemia
detect
frequent
rtpcr
rna
extract
directli
peripher
blood
mononuclear
cell
fip
usual
fatal
immunemedi
diseas
trigger
infect
fcov
affect
domest
wild
felin
pedersen
barlough
scott
elucid
fcov
epidemiolog
essenti
understand
fip
studi
fcov
infect
necessari
abl
detect
viru
unfortun
attempt
cultur
fcov
clinic
case
fip
cat
believ
expos
fcov
fail
pedersen
pedersen
et
al
hohdatsu
et
al
number
studi
method
demonstr
viru
cat
clinic
fip
found
pedersen
hok
b
cammarata
parodi
et
al
martinez
weiss
tammer
et
al
gener
littl
use
reliabl
diagnost
tool
start
studi
commerci
avail
test
detect
viru
within
chronicallyinfect
clinic
healthi
cat
sinc
persist
infect
cat
may
harbour
fcov
intestin
blood
possibl
tonsil
shed
viru
faec
saliva
cat
may
act
continu
sourc
infect
pedersen
addi
et
al
foley
et
al
abl
detect
cat
essenti
understand
role
dissemin
fcov
infect
also
determin
role
chronic
viraemia
may
play
induct
clinic
fip
initi
hypothesis
fipcaus
coronavirus
fipv
differ
nonpathogen
enter
coronavirus
fecv
abil
replic
within
macrophag
leav
gut
enter
bloodstream
pedersen
et
al
known
fcov
detect
use
rtpcr
techniqu
blood
healthi
cat
household
endem
fcov
herrewegh
et
al
herrewegh
et
al
richter
et
al
current
studi
involv
develop
success
method
cultur
fcov
rtpcr
assay
detect
fcov
genom
possibl
determin
whether
cat
remain
viraem
time
ii
whether
presenc
viraemia
led
ultim
develop
fip
iii
whether
type
methodolog
could
use
diagnosi
fip
four
group
cat
use
studi
group
contain
felin
patient
present
felin
centr
univers
bristol
veterinari
school
fip
subsequ
confirm
histopatholog
examin
post
mortem
materi
repres
eight
differ
breed
week
year
age
averag
age
month
show
sex
predisposit
seroposit
fcov
group
contain
clinic
healthi
yearold
specificpathogen
free
spf
cat
came
commerci
supplier
cat
natur
infect
undefin
gener
nonpathogen
fcov
seven
cat
assess
three
separ
occas
month
period
one
cat
assess
twice
cat
seroposit
fcov
group
contain
juvenil
fcov
antibodyposit
domest
short
hair
dsh
cat
mix
background
cat
grouphous
fcov
antibodyneg
juvenil
spf
cat
cat
succumb
fip
cat
still
aliv
week
first
sampl
resampl
prior
euthanasia
group
contain
clinic
healthi
pet
cat
nine
separ
pedigre
breed
catteri
repres
nine
differ
breed
week
year
age
averag
age
year
male
femal
fiftythre
cat
seroposit
fcov
rang
titr
indirect
immunofluoresc
median
within
month
preced
start
studi
least
one
case
fip
confirm
within
household
thirtyf
cat
reassess
month
sampl
thirtyf
cat
follow
time
three
month
month
month
five
month
four
cat
latter
group
assess
month
initi
sampl
well
month
cultur
sampl
collect
first
month
studi
assess
within
month
frozen
rna
extract
solut
tri
reagent
unfortun
later
sampl
held
storag
protract
period
result
degrad
rna
mani
sampl
despit
numer
attempt
salvag
sampl
recover
sampl
ml
blood
collect
cat
cephal
jugular
venepunctur
ethylenediaminetetraacet
acid
edta
tube
blood
sampl
first
centrifug
min
plasma
store
prior
assess
antifcov
antibodi
indirect
immunofluoresc
stoddart
et
al
buffi
coat
cell
dilut
final
volum
ml
rpmi
dutch
modif
cell
cultur
medium
supplement
vv
foetal
bovin
serum
sigma
mg
ml
lglutamin
sigma
mg
ml
gentamycin
concanavalin
con
sigma
lipopolysaccharid
lp
e
coli
serotyp
sigma
mg
ml
medium
cell
cultur
overnight
co
cm
flask
corn
uk
nonadher
cell
rins
multipl
wash
warm
steril
phosphat
buffer
salin
spb
adher
cell
sheet
seed
ml
whole
felin
embryo
wfe
cell
resuspend
cell
ml
eagl
minimum
essenti
medium
mem
sigma
supplement
vv
foetal
bovin
serum
wv
sodium
bicarbon
mg
ml
lglutamin
vv
nonessenti
amino
acid
gibcobrl
vv
lactalbumin
hydrolys
gibcobrl
mg
ml
gentamycin
cultur
maintain
week
transfer
cm
flask
corn
uk
day
cell
subcultur
approxim
oneinthre
everi
day
subcultur
twothird
cell
pellet
centrifug
minut
rins
spb
lyse
ml
rna
extract
solut
tri
reagent
sigma
frozen
pend
process
number
cell
cultureadapt
serotyp
fcov
strain
kind
gift
dr
nc
pedersen
includ
fipv
fipv
fipv
fipv
serotyp
fcov
consist
fipv
fecv
fipv
wellcom
fipv
primucel
virus
cultur
confluent
wfe
cell
inocul
viru
multipl
infect
moi
incub
h
cell
frozen
pend
process
cell
cultureadapt
viru
strain
gener
identifi
cytopath
effect
cpe
wfe
cell
cultur
signific
chang
rare
seen
field
strain
week
cultur
period
rna
extract
first
strand
synthesi
cdna
rna
extract
use
ml
tri
reagent
sigma
per
cultur
cell
ml
whole
anticoagul
blood
buffi
coat
plasma
serum
cell
lyse
repeat
pipet
lysat
chang
viscou
wateri
consist
lysat
vortex
prior
ad
ml
hplc
grade
chloroform
sigma
sampl
vortex
centrifug
min
hettich
zentrifugen
upper
aqueou
layer
transfer
fresh
ml
microcentrifug
tube
equival
volum
cold
isopropanol
sigma
ad
sampl
vortex
chill
least
hour
cold
chill
sampl
centrifug
min
supernat
discard
rna
pellet
wash
ad
ml
ethanol
molecular
grade
hayman
vortex
centrifug
minut
supernat
discard
rna
dri
briefli
air
prior
resuspend
diethylpyrocarbon
depc
treat
water
ml
per
cell
equival
amount
total
rna
extract
vari
mg
per
cell
cocultur
wfe
cell
usual
mg
per
cell
mg
per
cell
flask
infect
cell
cultureadapt
fcov
dnase
treatment
perform
heat
aliquot
rna
solut
minut
chill
quickli
ice
reaction
mixtur
adjust
contain
mg
ml
total
rna
mm
ph
mm
kcl
mm
mgcl
u
ml
dnase
molecular
biolog
grade
gibco
brl
depctreat
water
final
volum
ml
mixtur
incub
min
room
temperatur
reaction
termin
ad
mm
edta
incub
min
first
strand
synthesi
cdna
perform
use
commerci
avail
kit
superscript
preamplif
system
first
strand
cdna
synthesi
gibco
brl
accord
manufactur
recommend
use
oligodeoxythymidin
triphosph
dt
primer
adapt
rais
incub
temperatur
primer
probe
design
highli
conserv
cterminu
fcov
gene
de
groot
et
al
potenti
site
pcr
primer
identifi
consensu
sequenc
align
use
comput
assist
macvector
kodak
oligonucleotid
made
genosi
sequenc
shown
tabl
compon
first
round
pcr
combin
togeth
master
mix
adjust
give
reaction
condit
mm
ph
mm
kcl
mm
mgcl
mm
dntp
mix
u
ml
taq
dna
polymeras
amplitaq
gold
perkin
elmer
ml
vv
cdna
solut
mm
fcov
primer
no
depctreat
water
ad
make
final
volum
ml
pcr
perform
temperatur
cycler
heat
lid
pcr
protocol
consist
initi
incub
min
follow
cycl
melt
min
anneal
min
extens
min
final
extens
min
second
round
pcr
perform
necessari
per
first
round
use
seminest
primer
ml
first
round
product
control
incorpor
set
pcr
posit
control
includ
amplifi
cdna
gener
kitsuppli
control
rna
use
kitsuppli
pcr
primer
mm
use
experiment
cdna
sampl
known
strong
posit
fcov
neg
control
includ
use
cdna
prepar
known
neg
cell
cultur
cat
time
experiment
materi
process
plu
rt
primer
cdna
control
pcr
product
detect
agaros
gel
ethidium
bromid
stain
southern
blot
nylon
membran
hybondn
amersham
life
scienc
hybridis
probe
detect
use
enhanc
chemiluminesc
detect
system
ecl
amersham
life
scienc
per
manufactur
recommend
abil
detect
fcov
assess
number
cell
cultureadapt
strain
fcov
uninfect
cell
cultur
includ
neg
control
serotyp
fcov
fipv
fipvwellcom
fipv
primucel
fecv
detect
cycl
pcr
howev
serotyp
fcov
fipv
fipv
fipv
fipv
detect
pcr
cycl
fipv
fipv
detect
cycl
result
shown
product
detect
uninfect
cultur
even
two
round
cycl
pcr
methodolog
optimis
ensur
far
possibl
product
gener
produc
singl
band
agaros
gel
ran
expect
molecular
weight
probe
specif
fcov
fig
second
band
seen
number
sampl
amplifi
product
higher
molecular
weight
expect
primer
use
lower
expect
molecular
weight
primer
no
use
lane
occasion
shown
lane
extra
band
probe
posit
fcov
sampl
lane
band
run
expect
molecular
weight
fail
hybridis
fcov
probe
blood
sampl
cat
clinic
fip
assess
without
prior
cocultiv
presenc
fcov
rtpcr
virusspecif
probe
twentythre
cat
group
group
group
cat
whole
edta
anticoagul
blood
assess
group
cat
possibl
whole
anticoagul
blood
edta
heparin
separ
plasma
serum
evalu
presenc
fcov
twenti
group
cat
found
fcov
blood
group
cat
found
fcov
least
one
blood
fraction
margin
better
viru
detect
achiev
use
edta
anticoagul
heparin
anticoagul
intens
product
usual
greater
tabl
blood
sampl
cat
group
one
assess
without
prior
cultiv
see
cocultiv
wfe
cell
week
prior
rtpcr
hybridis
virusspecif
probe
blood
sampl
cat
group
cocultiv
wfe
cell
week
prior
rtpcr
tabl
rtpcr
sampl
two
cat
group
produc
band
correct
molecular
weight
fail
hybridis
virusspecif
probe
fourteen
cat
group
sampl
initi
week
cultur
sampl
six
cat
test
posit
fcov
pcr
week
cultur
cultur
test
posit
fcov
tabl
interestingli
one
cultur
test
posit
week
neg
fcov
rtpcr
probe
week
previous
anoth
previous
test
neg
rtpcr
posit
probe
uninfect
cell
cultur
remain
neg
throughout
two
month
initi
blood
sampl
sampl
collect
seven
cat
week
cultur
viru
detect
rtpcr
four
seven
cultur
tabl
month
sampl
collect
seven
cat
previous
reassess
plu
cat
assess
rtpcr
prior
cultur
fcov
detect
five
eight
sampl
number
sampl
test
posit
fell
first
week
cultur
rose
time
cultur
establish
week
tabl
fiftyf
cat
assess
initi
clinic
healthi
tabl
seven
cat
resampl
month
initi
sampl
initi
posit
fcov
rtpcr
probe
five
seven
cat
remain
posit
sampl
collect
later
studi
rna
success
extract
six
six
cat
initi
posit
fcov
rtpcr
probe
five
six
still
posit
month
tabl
studi
new
case
fip
develop
within
cat
test
household
use
rtpcr
assay
easili
grown
serotyp
fcov
fipv
fecv
fipv
wellcom
fipv
primucel
well
serotyp
fcov
fipv
detect
cell
cultur
sinc
primer
design
highli
conserv
region
bind
fcov
variant
inabl
detect
may
result
failur
strain
grow
wfe
cell
sinc
known
grow
poorli
cell
cultur
pedersen
et
al
high
detect
rate
sampl
field
case
suggest
fcov
strain
detect
rtpcr
assay
perform
hybridis
virusspecif
probe
greater
level
specif
achiev
plu
degre
amplif
signific
amplif
best
seen
tabl
sampl
healthi
spf
cat
assess
presenc
fcov
initi
blood
sampl
six
sampl
test
posit
rtpcr
alon
five
cat
found
infect
product
transfer
membran
probe
amplif
band
seen
ethidium
bromidestain
gel
hybridis
virusspecif
probe
sampl
demonstr
multipl
band
ethidium
bromid
stain
extra
band
probe
posit
interestingli
band
seen
run
desir
molecular
weight
detect
probe
could
two
reason
lack
hybridis
band
due
misprim
fcovspecif
ii
band
due
fcov
mutat
within
gene
prevent
probe
bind
support
latter
theori
find
least
extra
band
hybridis
probe
coronavirus
known
high
level
mutat
chen
baric
number
studi
rtpcr
techniqu
use
detect
fcov
sampl
clinic
fip
case
li
scott
egberink
et
al
herrewegh
et
al
herrewegh
et
al
fehr
et
al
richter
et
al
studi
involv
fresh
formalinfix
tissu
li
scott
other
plasma
serum
ascit
pleural
fluid
examin
herrewegh
et
al
herrewegh
et
al
fehr
et
al
richter
et
al
found
viru
approxim
blood
sampl
confirm
case
fip
valu
agreement
previou
author
found
case
virusposit
herrewegh
et
al
found
plasma
sensit
serum
analys
edta
anticoagul
blood
presenc
fcov
studi
similar
trend
note
studi
healthi
cat
live
within
household
endem
fcov
also
shown
viraem
fcov
find
agreement
egberink
et
al
herrewegh
et
al
herrewegh
et
al
richter
et
al
howev
egberink
et
al
found
cat
viraem
herrewegh
et
al
herrewegh
et
al
found
cat
affect
richter
et
al
found
cat
posit
result
find
cat
viraem
best
agreement
latter
studi
studi
primer
region
viru
use
presenc
viraemia
success
monitor
month
healthi
cat
abl
show
viraemia
persist
five
seven
cat
least
month
five
eight
cat
least
month
five
six
cat
least
month
none
persistentlyinfect
cat
develop
sign
clinic
diseas
within
period
observ
given
overal
lack
new
fip
case
within
catteri
appear
logic
surmis
cat
persist
viraemia
associ
develop
diseas
studi
would
need
confirm
cat
studi
viraem
seroposit
fcov
presenc
antibodi
gener
correl
well
presenc
viru
viru
detect
antibodyposit
cat
two
viraem
cat
lack
specif
antibodi
seroneg
report
previous
cat
clinic
fip
scott
spark
et
al
fehr
et
al
healthi
fcovinfect
individu
fehr
et
al
richter
et
al
herrewegh
et
al
fehr
et
al
herrewegh
et
al
found
consider
proport
healthi
cat
mix
background
seroneg
fcov
despit
rtpcr
posit
eight
cat
five
cat
respect
richter
et
al
found
healthi
viraem
cat
antibodyneg
along
six
cat
clinic
fip
number
possibl
appar
lack
serolog
respons
clinic
ill
cat
lack
detect
antibodi
may
due
bound
form
immun
complex
scott
howev
sinc
seroneg
cat
studi
clinic
ill
appear
unlik
explan
perhap
like
lack
antibodi
relat
recent
infect
theori
support
richter
et
al
found
seven
viraem
seroneg
cat
less
week
age
age
kitten
like
lost
matern
deriv
antibodi
may
recent
expos
viru
addi
jarrett
foley
et
al
possibl
recent
infect
may
also
explain
three
five
case
identifi
herrewegh
et
al
sinc
three
month
age
remain
healthi
seroneg
viraem
cat
studi
richter
et
al
herrewegh
et
al
wide
rang
age
interestingli
three
cat
previous
test
seroposit
fcov
two
seroneg
cat
studi
one
month
age
avail
studi
year
age
remain
seroneg
follow
year
observ
becam
seroposit
month
later
find
would
appear
viraem
cat
may
intermitt
seroposit
other
may
fail
produc
detect
antibodi
signific
find
develop
diseas
remain
unclear
studi
see
cat
live
within
larg
group
pedigre
breed
catteri
like
viraem
expos
fcov
sinc
differ
incid
viraemia
healthi
cat
suffer
fip
rtpcr
assay
consid
suitabl
test
diagnosi
fip
howev
test
much
recommend
detect
persistentlyinfect
carrier
cat
screen
cat
prior
introduct
fcovfre
breed
coloni
also
import
asset
ongo
studi
fcov
epidemiolog
cocultiv
system
shown
success
vitro
method
grow
field
strain
fcov
similar
percentag
sampl
test
posit
fcov
direct
rtpcr
week
cocultiv
seen
clinic
fip
sampl
approxim
posit
direct
rtpcr
posit
cocultiv
rtpcr
posit
cocultiv
rtpcr
probe
interestingli
sampl
individu
cat
assess
cultur
system
less
predict
presum
virus
adapt
celllin
place
differ
isol
differ
abil
possibl
initi
period
adapt
input
viru
fail
replic
result
reduc
number
posit
sampl
adapt
viru
began
grow
strongli
becam
detect
adapt
period
appear
take
least
week
sampl
without
cultur
sampl
gave
best
chanc
viru
detect
follow
assess
either
week
cultur
viru
difficult
detect
sampl
cultur
week
preval
fcov
viraemia
may
underestim
group
cat
assess
time
exampl
may
seen
cat
group
tabl
cat
assess
sampl
cultur
week
fifteen
cat
found
infect
rtpcr
compar
ten
cat
group
assess
week
cultur
perhap
surprisingli
number
sampl
test
neg
initi
becam
posit
week
cultur
control
crosscontamin
stringent
like
scenario
level
viru
undetect
initi
sampl
cocultiv
allow
amplif
may
case
sampl
number
fcovinfect
white
blood
cell
amount
intracellular
viru
small
weiss
scott
vitro
cultiv
cell
may
stimul
viru
express
andor
replic
aid
detect
weiss
scott
studi
mice
perform
show
antigenor
mitogenstimul
lymphocyt
acquir
capac
replic
exogen
endogen
virus
hirsch
also
vitro
mainten
pbmc
infect
anim
activ
express
replic
certain
virus
produc
persist
infect
stock
ferrer
row
et
al
similarli
pbmc
fcovinfect
cat
may
acquir
capac
express
replic
viru
vitro
coinfect
cell
releas
solubl
factor
eg
cytokin
cultur
medium
activ
viru
within
cell
weiss
scott
cocultiv
system
shown
suitabl
method
growth
field
strain
fcov
particularli
combin
rtpcr
assay
allow
continu
studi
virus
